Pluripotent stem cells, both induced pluripotent stem cells and embryonic stem cells, represent an attractive, physiologically relevant cellular system for disease modeling, drug discovery, and cell-based therapy. However, technical challenges persist in the standardization of culture growth conditions and differentiation protocols. The Scientist brings together a panel of experts to discuss challenges and strategies for optimizing your pluripotent stem cell culture. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences using stem cells.
Topics to be covered:
Dr. Paul W. Burridge
Assistant Professor
Department of Pharmacology
Center for Pharmacogenomics
Northwestern University Feinberg School of Medicine
Dr. Derrick Rancourt
Professor
Departments of Oncology, Biochemistry & Molecular Biology, and Medical Genetics
University of Calgary
Dr. Mark Tomishima
Head, SKI Stem Cell Research Facility
Sloan Kettering Institute
